☆ 4.5 Review

Biological markers for therapeutic trials in Alzheimer's disease - Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease

NEUROBIOLOGY OF AGING (2003)

Get Full Text
Add to Collection

Journal

NEUROBIOLOGY OF AGING
Volume 24, Issue 4, Pages 521-536

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/S0197-4580(03)00002-2

Keywords

Alzheimer's disease; mild cognitive impairment (MCI); biomarkers; surrogate endpoints; disease modification; drug development; dementia; screening; diagnostics; prognostics; enrichment strategy; bioassay; progression; CSF; blood

Categories

Geriatrics & Gerontology Neurosciences

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.